News from NORD

NCATS Unveils Toolkit for Patient-Focused Therapy Development

Publish date: May 7, 2018

 

The National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) has developed a new toolkit for the rare disease community to facilitate therapeutics research and development. Learn more about the toolkit here .

Recommended Reading

Monitoring for Infection in MS Patients
Clinician Reviews
The ACA and Multiple Sclerosis
Clinician Reviews
Chikungunya infection in children masquerades as SJS-TEN
Clinician Reviews
Register Now for NORD’s Rare Impact Awards Celebration
Clinician Reviews
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
Clinician Reviews
RFPs Available for the Study of Three Rare Diseases
Clinician Reviews
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
Clinician Reviews
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
Clinician Reviews
NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans
Clinician Reviews
Running for Rare Team Participates in Boston Marathon to Raise Funds for Undiagnosed Patients
Clinician Reviews